Danaher names Matthew Gugino as new CFO effective February 2026

Danaher Corporation (NYSE: DHR) announced Matthew Gugino will succeed Matthew McGrew as chief financial officer effective February 28, 2026. McGrew will transition to executive vice president following the change and begin a gradual retirement after more than 20 years with the company.

Gugino currently serves as Group Chief Financial Officer of Danaher's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis. He joined the company in 2013 as Director of Investor Relations and has held roles of increasing responsibility, including Vice President of Investor Relations from 2014 to 2022.

"Matt McGrew's financial leadership over the past two decades has been instrumental in shaping the Danaher you see today," said Rainer Blair, President and Chief Executive Officer. "He played a pivotal role in the acquisition of Cytiva, the launches of Envista and Veralto as public companies, and navigating through the pandemic."

McGrew has served as Danaher's CFO since January 2019. He joined the company in 2004 as Director of M&A Finance and previously held positions including Vice President of Investor Relations and Danaher Group CFO. During his tenure as CFO, the company nearly doubled both its revenue and market capitalization, according to the company's statement.

Before joining Danaher, Gugino worked as Vice President of Equity Research at Barclays and Morgan Stanley, and as an Associate at KPMG. He holds a Bachelor of Science degree in Accounting and a Master of Accountancy and Professional Consultancy from Villanova University.

The Washington-based company operates in the life sciences and diagnostics sectors.

You May Also Be Interested In

• Metallus CEO Michael Williams to retire; Kris Westbrooks named successor
• Ranger Energy to buy Step Energy's U.S. coiled tubing assets for $27.5M
• Femcare acquires UK harm reduction firm Orion for £3.6M